UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Phase 1

Recruiting

Conditions: Gall Bladder Cancer
Breast Cancer
Soft Tissue Sarcoma
Vulvar Cancer
Bile Duct Cancer
Ovarian Cancer
Pancreatic Adenocarcinoma
Prostate Cancer
Neuroendocrine Tumors

Interventions: Drug: Atezolizumab
Drug: Tivozanib

First Posted Date: 2021-08-11

Last Posted Date: 2024-03-15

Lead Sponsor: University of Florida

Target Recruit Count: 29

Registration Number: NCT05000294

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Women Helping Women - Lung Cancer Screening

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Behavioral: Enhanced CHW Intervention

First Posted Date: 2021-07-30

Last Posted Date: 2023-05-10

Lead Sponsor: University of Florida

Target Recruit Count: 46

Registration Number: NCT04983134

Locations: 🇺🇸
UF Health Cancer Center, Gainesville, Florida, United States

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

Phase 1

Terminated

Conditions: Glioblastoma

Interventions: Biological: Autologous DCs derived from PBMC loaded with RNA encoding the human CMV matrix protein pp65-flLAMP plus GM-CSF

First Posted Date: 2021-07-15

Last Posted Date: 2024-11-19

Lead Sponsor: University of Florida

Target Recruit Count: 6

Registration Number: NCT04963413

Locations: 🇺🇸
University of Florida Health Shands Hospital, Gainesville, Florida, United States

Low Dose ICG for Biliary Tract and Tumor Imaging

Phase 2

Completed

Conditions: Cholecystitis
Hepatocellular Carcinoma
Liver Metastases

Interventions: Drug: Indocyanine green
Device: PINPOINT Endoscopic Fluorescence

First Posted Date: 2021-06-28

Last Posted Date: 2023-08-30

Lead Sponsor: University of Florida

Target Recruit Count: 60

Registration Number: NCT04942665

Locations: 🇺🇸
University of Florida Health Shands, Gainesville, Florida, United States

SGA for TEE: Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease.

Not Applicable

Withdrawn

Conditions: Cardiopulmonary Disease

Interventions: Procedure: TEE with Deep Sedation
Procedure: TEE with SGA

First Posted Date: 2021-06-25

Last Posted Date: 2024-06-21

Lead Sponsor: University of Florida

Registration Number: NCT04939220

Locations: 🇺🇸
UF Health Jacksonville, Jacksonville, Florida, United States

Characterizing the Effects of Family History of Alcoholism on Alcohol Analgesia

Not Applicable

Completed

Conditions: Effects of Family History of Alcoholism and Sex on Alcohol Analgesia

Interventions: Drug: Ethanol
Other: Placebo

First Posted Date: 2021-06-14

Last Posted Date: 2024-08-13

Lead Sponsor: University of Florida

Target Recruit Count: 125

Registration Number: NCT04925076

Locations: 🇺🇸
Center for Pain Research and Behavioral Health at UF Health, Gainesville, Florida, United States

Effect of Beet Juice Supplementation on Vascular and Inspiratory Muscle Function

Not Applicable

Recruiting

Conditions: Coronary Artery Disease

Interventions: Dietary Supplement: Nitrate depleted beetroot juice
Dietary Supplement: Nitrate rich beetroot juice

First Posted Date: 2021-06-10

Last Posted Date: 2024-04-16

Lead Sponsor: University of Florida

Target Recruit Count: 24

Registration Number: NCT04920799

Locations: 🇺🇸
Integrative Cardiovascular Physiology Laboratory, University of Florida, Gainesville, Florida, United States

Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

Phase 2

Recruiting

Conditions: Peripheral Nerve Sheath Tumor

Interventions: Drug: Tazemetostat

First Posted Date: 2021-06-08

Last Posted Date: 2024-10-07

Lead Sponsor: University of Florida

Target Recruit Count: 24

Registration Number: NCT04917042

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation

Not Applicable

Completed

Conditions: Cervical Dystonia

Interventions: Device: rTMS

First Posted Date: 2021-06-07

Last Posted Date: 2024-10-08

Lead Sponsor: University of Florida

Target Recruit Count: 5

Registration Number: NCT04916444

Locations: 🇺🇸
University of Florida Health Norman Fixel Institute for Neurological Diseases, Gainesville, Florida, United States

Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission

Phase 2

Terminated

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cytarabine

First Posted Date: 2021-06-04

Last Posted Date: 2024-10-07

Lead Sponsor: University of Florida

Target Recruit Count: 5

Registration Number: NCT04914676

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy